Determining direct, indirect healthcare and social costs for diabetic retinopathy management: a systematic review.

ABSTRACT:

Introduction

Diabetic retinopathy (DR) is a rapidly growing global public health threat; it affects 1 in 3 people with diabetes and is still the leading cause of blindness among the working-age population. The management of diabetic retinopathy is becoming more advanced and effective but is highly expensive compared to other ocular diseases.

Aim

To report direct medical, indirect medical, and nonmedical costs of diabetic retinopathy in developed and developing countries through a systematic review.

Methods

Related articles published in the PubMed, Google Scholar, and EMBASE electronic databases from 1985 to 2022 were identified using the keywords direct medical and indirect medical and social costs of diabetic retinopathy. However, previous systematic reviews, abstrac

SUBMITTER: Benhamza M 

PROVIDER: S-EPMC11441148 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature